770
Participants
Start Date
April 28, 2022
Primary Completion Date
July 14, 2025
Study Completion Date
July 14, 2025
Nivolumab-relatlimab FDC
Specified dose on specified days
Regorafenib
Specified dose on specified days
TAS-102
Specified dose on specified days
Local Institution - 0121, Zhongzheng
Local Institution - 0128, Changhua
Local Institution - 0076, Tainan City
Local Institution - 0062, Woluwé-Saint-Lambert
Local Institution - 0022, Ciudad Autónoma Buenos Aires
Local Institution - 0024, Ciudad Autónoma Buenos Aires
Local Institution - 0114, Westmead
Local Institution - 0098, Wagga Wagga
Local Institution - 0070, Edegem
Local Institution - 0120, Leuven
Local Institution - 0069, Bern
Local Institution - 0021, Melbourne
Local Institution - 0010, Clayton
Local Institution - 0001, Greenslopes
Local Institution - 0057, Aarau
Local Institution - 0131, Salzburg
Local Institution - 0027, Murdoch
Local Institution - 0030, Graz
Local Institution - 0023, Río Grande
Local Institution - 0068, Ghent
Local Institution - 0078, Klagenfurt
Local Institution - 0073, Goyang-si, Gyeonggi-do
Local Institution - 0055, Berlin
Local Institution - 0129, Seongnamsi Bundanggu
Local Institution - 0017, Caen
Local Institution - 0112, A Coruña
Local Institution - 0091, Genova
Local Institution - 0045, Milan
Local Institution - 0046, Milan
Local Institution - 0040, Hamburg
Local Institution - 0090, Dijon
Local Institution - 0132, Richmond
Local Institution - 0099, Hořovice
Local Institution - 0009, Durham
Local Institution - 0102, Madrid
Local Institution - 0113, Madrid
Local Institution - 0008, Charleston
Local Institution - 0031, Atlanta
Local Institution - 0066, Bordeaux
Local Institution - 0025, Miami
Local Institution - 0148, Padua
Local Institution - 0035, Seville
Local Institution - 0059, Reggio Emilia
Local Institution - 0101, Essen
Local Institution - 0082, Cincinnati
Local Institution - 0081, Fort Wayne
Local Institution - 0116, Zaragoza
Local Institution - 0096, Sioux Falls
Local Institution - 0041, Frankfurt A. Main
Local Institution - 0054, Mannheim
Local Institution - 0036, Lyon
Local Institution - 0077, Tainan City
Local Institution - 0056, Reutlingen
Local Institution - 0089, Paris
Local Institution - 0115, Napoli
Local Institution - 0061, Napoli
Local Institution - 0034, München
Local Institution - 0111, Kaohsiung City
Local Institution - 0039, Suresnes
Local Institution - 0020, Levallois-Perret
Local Institution - 0060, Catania
Local Institution - 0053, Würzburg
Local Institution - 0122, Beijing
Local Institution - 0149, Shenyang
Local Institution - 0109, Singapore
Local Institution - 0153, Shanghai
Local Institution - 0143, Nanjing
Local Institution - 0146, Huaian
Local Institution - 0142, Jinan
Local Institution - 0150, Tianjin
Local Institution - 0139, Hangzhou
Local Institution - 0160, Hangzhou
Local Institution - 0087, Singapore
Local Institution - 0134, Chongqing
Local Institution - 0138, Changsha
Local Institution - 0158, Changsha
Local Institution - 0126, Wuhan
Local Institution - 0164, Wuhan
Local Institution - 0151, Guangzhou
Local Institution - 0144, Chengdu
Local Institution - 0152, Xi'an
Local Institution - 0110, Osaka
Local Institution - 0015, Santiago
Local Institution - 0033, Santiago
Local Institution - 0044, Springdale
Local Institution - 0012, Los Angeles
Local Institution - 0117, Norwich
Local Institution - 0071, Boise
Massachusetts General Hospital,, Boston
Local Institution - 0042, Ann Arbor
Local Institution - 0043, East Brunswick
Local Institution - 0095, Columbus
Local Institution - 0147, Philadelphia
Local Institution - 0127, Nashville
Local Institution - 0097, Fort Worth
Local Institution - 0005, Madison
Local Institution - 0026, Ciudad Autónoma Buenos Aires
Local Institution - 0003, Edmonton
Local Institution - 0014, Ottawa
Local Institution - 0007, Toronto
Local Institution - 0019, Montreal
Local Institution - 0104, Montreal
Local Institution - 0004, Sherbrooke
Local Institution - 0141, Taiyuan
Local Institution - 0016, Hradec Králové
Local Institution - 0100, Olomouc
Local Institution - 0123, Ostrava
Local Institution - 0064, Prague
Local Institution - 0107, Chiba
Local Institution - 0103, Chūōku
Local Institution - 0105, Hidaka-shi
Local Institution - 0154, Kasama-Shi
Local Institution - 0084, Kashiwa-Shi
Local Institution - 0086, Kawasaki-Shi
Local Institution - 0119, Kitaadachi-gun
Local Institution - 0108, Kōtoku
Local Institution - 0118, Matsuyama
Local Institution - 0088, Sapporo
Local Institution - 0083, Suita-Shi
Local Institution - 0085, Sunto-gun
Local Institution - 0124, Yokohama
Local Institution - 0050, Amsterdam
Local Institution - 0051, Warsaw
Local Institution - 0037, Warsaw
Local Institution - 0018, Krakow
Local Institution - 0052, Warsaw
Local Institution - 0106, San Juan
Local Institution - 0072, Seoul
Local Institution - 0092, Seoul
Local Institution - 0075, Seoul
Local Institution - 0074, Seoul
Local Institution - 0029, Badalona
Local Institution - 0093, Barcelona
Local Institution - 0080, Barcelona
Local Institution - 0038, Stockholm
Local Institution - 0135, Stockholm
Local Institution - 0058, Uppsala
Local Institution - 0067, Gothenburg
Local Institution - 0094, Malmo
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY